Review
The pharmacology of agents used in the treatment of pulmonary mycoses
- PMID: 3021382
Item in Clipboard
Review
The pharmacology of agents used in the treatment of pulmonary mycoses
Clin Chest Med.
1986 Sep.
Abstract
The different antifungals currently used in pulmonary mycoses consist of polyene antibiotics, the antimetabolite 5-fluorocytosine, and azole derivatives. The pharmacologic profiles, mechanisms of action, pharmacokinetics, clinical indications for use, dosage recommendations, side effects, and drug interactions for these agents are presented.
Similar articles
-
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].Ann Biol Clin (Paris). 1989;47(9):546-9. Ann Biol Clin (Paris). 1989. PMID: 2558599 French.
-
Recent advances in the treatment of systemic fungal infections.Methods Find Exp Clin Pharmacol. 1987 Nov;9(11):769-78. Methods Find Exp Clin Pharmacol. 1987. PMID: 2834615 Review.
-
[Therapy of pulmonary mycoses].Dtsch Med Wochenschr. 1992 Nov 6;117(45):1725-9. doi: 10.1055/s-2007-1024318. Dtsch Med Wochenschr. 1992. PMID: 1330477 Review. German. No abstract available.
-
[Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].Mykosen. 1981 May;24(5):261-74. Mykosen. 1981. PMID: 6265772 German. No abstract available.
-
Cyclosporine interactions with miconazole and other azole-antimycotics: a case report and review of the literature.J Heart Lung Transplant. 1992 Nov-Dec;11(6):1127-32. J Heart Lung Transplant. 1992. PMID: 1457436 Review.